{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:43:05Z","timestamp":1788226985435,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41443-025-01026-5","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:33:46Z","timestamp":1744353226000},"page":"507-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Update on the prevalence and pathophysiology of sickle cell priapism: a narrative review"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1683-0079","authenticated-orcid":false,"given":"William","family":"Akakpo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6560-8605","authenticated-orcid":false,"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"1026_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","volume":"7","author":"GA Broderick","year":"2010","unstructured":"Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010;7:476\u2013500.","journal-title":"J Sex Med"},{"key":"1026_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/jsm.12816","volume":"12","author":"UA Anele","year":"2015","unstructured":"Anele UA, Burnett AL. Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors. J Sex Med. 2015;12:713\u20139.","journal-title":"J Sex Med"},{"key":"1026_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.4111\/kju.2013.54.12.816","volume":"54","author":"PH Song","year":"2013","unstructured":"Song PH, Moon KH. Priapism: current updates in clinical management. Korean J Urol. 2013;54:816\u201323.","journal-title":"Korean J Urol"},{"key":"1026_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0022-5347(17)45549-2","volume":"135","author":"MA Spycher","year":"1986","unstructured":"Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol. 1986;135:142\u20137.","journal-title":"J Urol"},{"key":"1026_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1743-6109.2011.02288.x","volume":"9","author":"TJ Bivalacqua","year":"2012","unstructured":"Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL. New insights into the pathophysiology of sickle cell disease-associated priapism. J Sex Med. 2012;9:79\u201387.","journal-title":"J Sex Med"},{"key":"1026_CR6","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.juro.2013.03.118","volume":"190","author":"F Roghmann","year":"2013","unstructured":"Roghmann F, Becker A, Sammon JD, Ouerghi M, Sun M, Sukumar S, et al. Incidence of priapism in emergency departments in the United States. J Urol. 2013;190:1275\u201380.","journal-title":"J Urol"},{"key":"1026_CR7","doi-asserted-by":"publisher","unstructured":"GBD 2021 Sickle Cell Disease Collaborators. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023;10:e585\u201399. https:\/\/doi.org\/10.1016\/S2352-3026(23)00118-7. Erratum in: Lancet Haematol. 2023;10:e574. https:\/\/doi.org\/10.1016\/S2352-3026(23)00215-6.","DOI":"10.1016\/S2352-3026(23)00118-7"},{"key":"1026_CR8","doi-asserted-by":"publisher","first-page":"100339","DOI":"10.1016\/j.esxm.2021.100339","volume":"9","author":"N Whyte","year":"2021","unstructured":"Whyte N, Morrison-Blidgen B, Asnani M. Priapism in sickle cell disease: an evaluation of the knowledge of an at risk population in Jamaica. Sex Med. 2021;9:100339.","journal-title":"Sex Med"},{"key":"1026_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12301-023-00376-0","volume":"29","author":"AJN De Niro","year":"2023","unstructured":"De Niro AJN, Duarsa GWK, Yudiana IW, Prayudi NG, Tirtayasa PMW, Santosa KB, Kloping YP. Predictors of priapism incidence and recurrence in sickle cell disease patients. Afr J Urol. 2023;29:45.","journal-title":"Afr J Urol"},{"key":"1026_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/hematology.2022000380","volume":"2022","author":"IM Idris","year":"2022","unstructured":"Idris IM, Burnett AL, DeBaun MR. Epidemiology and treatment of priapism in sickle cell disease. Hematol Am Soc Hematol Educ Program. 2022;2022:450\u20138.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1026_CR11","doi-asserted-by":"publisher","first-page":"e0153257","DOI":"10.1371\/journal.pone.0153257","volume":"11","author":"B Dupervil","year":"2016","unstructured":"Dupervil B, Grosse S, Burnett A, Parker C. Emergency department visits and inpatient admissions associated with priapism among males with sickle cell disease in the United States, 2006\u20132010. PLoS ONE. 2016;11:e0153257.","journal-title":"PLoS ONE"},{"key":"1026_CR12","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1001\/archinte.1980.00330220022011","volume":"140","author":"AM Emond","year":"1980","unstructured":"Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med. 1980;140:1434\u20137.","journal-title":"Arch Intern Med"},{"key":"1026_CR13","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/j.1464-410X.2011.10367.x","volume":"108","author":"P Kheirandish","year":"2011","unstructured":"Kheirandish P, Chinegwundoh F, Kulkarni S. Treating stuttering priapism. BJU Int. 2011;108:1068\u201372.","journal-title":"BJU Int"},{"key":"1026_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpurol.2013.07.024","volume":"10","author":"JF Donaldson","year":"2014","unstructured":"Donaldson JF, Rees RW, Steinbrecher HA. Priapism in children: a comprehensive review and clinical guideline. J Pediatr Urol. 2014;10:11\u201324.","journal-title":"J Pediatr Urol"},{"key":"1026_CR15","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1073\/pnas.052712499","volume":"99","author":"KJ Hurt","year":"2002","unstructured":"Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarity JL, et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci USA. 2002;99:4061\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1026_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2174\/1389450115666141111111842","volume":"16","author":"UA Anele","year":"2015","unstructured":"Anele UA, Morrison BF, Burnett AL. Molecular pathophysiology of priapism: emerging targets. Curr Drug Targets. 2015;16:474\u201383.","journal-title":"Curr Drug Targets"},{"key":"1026_CR17","unstructured":"Corbin JD. Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int J Impot Res. 2004;16:S4\u20137."},{"key":"1026_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1524-6175.2006.06026.x","volume":"8","author":"AL Burnett","year":"2006","unstructured":"Burnett AL. The role of nitric oxide in erectile dysfunction: implications for medical therapy. J Clin Hypertens. 2006;8:53\u201362.","journal-title":"J Clin Hypertens"},{"key":"1026_CR19","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1111\/j.1743-6109.2009.01359.x","volume":"6","author":"TJ Bivalacqua","year":"2009","unstructured":"Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, Champion HC. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J Sex Med. 2009;6:2494\u2013504.","journal-title":"J Sex Med"},{"key":"1026_CR20","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1073\/pnas.0407183102","volume":"102","author":"HC Champion","year":"2005","unstructured":"Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA. 2005;102:1661\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1026_CR21","doi-asserted-by":"publisher","first-page":"e68028","DOI":"10.1371\/journal.pone.0068028","volume":"8","author":"TJ Bivalacqua","year":"2013","unstructured":"Bivalacqua TJ, Musicki B, Hsu LL, Berkowitz DE, Champion HC, Burnett AL. Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress. PLoS ONE. 2013;8:e68028.","journal-title":"PLoS ONE"},{"key":"1026_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","volume":"189","author":"G Lagoda","year":"2013","unstructured":"Lagoda G, Sezen SF, Cabrini MR, Musicki B, Burnett AL. Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis. J Urol. 2013;189:762\u20138.","journal-title":"J Urol"},{"key":"1026_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Investig. 2017;127:750\u201360.","journal-title":"J Clin Investig"},{"key":"1026_CR24","doi-asserted-by":"publisher","first-page":"961534","DOI":"10.3389\/fphys.2022.961534","volume":"13","author":"PDS Pereira","year":"2022","unstructured":"Pereira PDS, Pereira DA, Calmasini FB, Reis LO, Brinkman N, Burnett AL, et al. Haptoglobin treatment contributes to regulating nitric oxide signal and reduces oxidative stress in the penis: a preventive treatment for priapism in sickle cell disease. Front Physiol. 2022;13:961534.","journal-title":"Front Physiol"},{"key":"1026_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0163-7258(01)00152-8","volume":"91","author":"R Tabrizchi","year":"2001","unstructured":"Tabrizchi R, Bedi S. Pharmacology of adenosine receptors in the vasculature. Pharmacol Ther. 2001;91:133\u201347.","journal-title":"Pharmacol Ther"},{"key":"1026_CR26","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1172\/JCI33467","volume":"118","author":"T Mi","year":"2008","unstructured":"Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, Xia LW, et al. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Investig. 2008;118:1491\u2013501.","journal-title":"J Clin Investig"},{"key":"1026_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/ijir.2015.5","volume":"27","author":"S Fu","year":"2015","unstructured":"Fu S, Davies KP. Opiorphin-dependent upregulation of CD73 (a key enzyme in the adenosine signaling pathway) in corporal smooth muscle cells exposed to hypoxic conditions and in corporal tissue in pre-priapic sickle cell mice. Int J Impot Res. 2015;27:140\u20135.","journal-title":"Int J Impot Res"},{"key":"1026_CR28","first-page":"12","volume":"43","author":"O Parshad","year":"1994","unstructured":"Parshad O, Stevens MC, Preece MA, Thomas PW, Serjeant GR. The mechanism of low testosterone levels in homozygous sickle-cell disease. West Indian Med J. 1994;43:12\u20134.","journal-title":"West Indian Med J"},{"key":"1026_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11255-014-0864-1","volume":"47","author":"BF Morrison","year":"2015","unstructured":"Morrison BF, Anele UA, Reid ME, Madden WA, Feng Z, Burnett AL. Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease? Int Urol Nephrol. 2015;47:47\u201352.","journal-title":"Int Urol Nephrol"},{"key":"1026_CR30","doi-asserted-by":"publisher","first-page":"892184","DOI":"10.3389\/fendo.2022.892184","volume":"13","author":"B Musicki","year":"2022","unstructured":"Musicki B, Burnett AL. Testosterone deficiency in sickle cell disease: recognition and remediation. Front Endocrinol. 2022;13:892184.","journal-title":"Front Endocrinol"},{"key":"1026_CR31","doi-asserted-by":"publisher","first-page":"e0128694","DOI":"10.1371\/journal.pone.0128694","volume":"10","author":"B Musicki","year":"2015","unstructured":"Musicki B, Zhang Y, Chen H, Brown TR, Zirkin BR, Burnett AL. Mechanism of testosterone deficiency in the transgenic sickle cell mouse. PLoS ONE. 2015;10:e0128694.","journal-title":"PLoS ONE"},{"key":"1026_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/pgmj.63.736.95","volume":"63","author":"DN Osegbe","year":"1987","unstructured":"Osegbe DN, Akinyanju OO. Testicular dysfunction in men with sickle cell disease. Postgrad Med J. 1987;63:95\u20138.","journal-title":"Postgrad Med J"},{"key":"1026_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.2047-2927.2013.00084.x","volume":"1","author":"BF Morrison","year":"2013","unstructured":"Morrison BF, Reid M, Madden W, Burnett AL. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Andrology. 2013;1:576\u201382.","journal-title":"Andrology"},{"key":"1026_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2141.2004.05295.x","volume":"128","author":"VG Nolan","year":"2005","unstructured":"Nolan VG, Baldwin C, Ma Q, Wyszynski DF, Amirault Y, Farrell JJ, et al. Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. Br J Haematol. 2005;128:266\u201372.","journal-title":"Br J Haematol"},{"key":"1026_CR35","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.jsxm.2019.09.012","volume":"16","author":"M Cintho Ozahata","year":"2019","unstructured":"Cintho Ozahata M, Page GP, Guo Y, Ferreira JE, Dinardo CL, Carneiro-Proietti ABF, et al. Clinical and genetic predictors of priapism in sickle cell disease: results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study. J Sex Med. 2019;16:1988\u201399.","journal-title":"J Sex Med"},{"key":"1026_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.tracli.2019.01.003","volume":"26","author":"BVKS Lakkakula","year":"2019","unstructured":"Lakkakula BVKS. Association between MTHFR 677C\u2009>\u2009T polymorphism and vascular complications in sickle cell disease: a meta-analysis. Transfus Clin Biol. 2019;26:284\u20138.","journal-title":"Transfus Clin Biol"},{"key":"1026_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1152\/physrev.00036.2017","volume":"99","author":"J Tejero","year":"2019","unstructured":"Tejero J, Shiva S, Gladwin MT. Sources of vascular nitric oxide and reactive oxygen species and their regulation. Physiol Rev. 2019;99:311\u201379.","journal-title":"Physiol Rev"},{"key":"1026_CR38","doi-asserted-by":"publisher","first-page":"e0166291","DOI":"10.1371\/journal.pone.0166291","volume":"11","author":"FH Silva","year":"2016","unstructured":"Silva FH, Claudino MA, Calmasini FB, Alexandre EC, Franco-Penteado C, Burnett AL, et al. Sympathetic hyperactivity, increased tyrosine hydroxylase and exaggerated corpus cavernosum relaxations associated with oxidative stress plays a major role in the penis dysfunction in townes sickle cell mouse. PLoS ONE. 2016;11:e0166291.","journal-title":"PLoS ONE"},{"key":"1026_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ijir.2010.27","volume":"22","author":"ND Kanika","year":"2010","unstructured":"Kanika ND, Melman A, Davies KP. Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue. Int J Impot Res. 2010;22:363\u201373.","journal-title":"Int J Impot Res"},{"key":"1026_CR40","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1111\/j.1743-6109.2012.02798.x","volume":"9","author":"B Musicki","year":"2012","unstructured":"Musicki B, Liu T, Sezen SF, Burnett AL. Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis. J Sex Med. 2012;9:1980\u20137.","journal-title":"J Sex Med"},{"key":"1026_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/83258","volume":"7","author":"K Chitaley","year":"2001","unstructured":"Chitaley K, Wingard CJ, Clinton Webb R, Branam H, Stopper VS, Lewis RW, et al. Antagonism of rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med. 2001;7:119\u201322.","journal-title":"Nat Med"},{"key":"1026_CR42","doi-asserted-by":"publisher","first-page":"510.e7","DOI":"10.1016\/j.urology.2010.02.050","volume":"76","author":"TJ Bivalacqua","year":"2010","unstructured":"Bivalacqua TJ, Ross AE, Strong TD, Gebska MA, Musicki B, Champion HC, et al. Attenuated RhoA\/Rho-kinase signaling in penis of transgenic sickle cell mice. Urology. 2010;76:510.e7\u201312.","journal-title":"Urology"},{"key":"1026_CR43","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jsm.12756","volume":"12","author":"U Patel","year":"2015","unstructured":"Patel U, Sujenthiran A, Watkin N. Penile Doppler ultrasound in men with stuttering priapism and sickle cell disease - a labile baseline diastolic velocity is a characteristic finding. J Sex Med. 2015;12:549\u201356.","journal-title":"J Sex Med"},{"key":"1026_CR44","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.115.021015","volume":"134","author":"B Ranque","year":"2016","unstructured":"Ranque B, Menet A, Boutouyrie P, Diop IB, Kingue S, Diarra M, et al. Arterial stiffness impairment in sickle cell disease associated with chronic vascular complications: the multinational African CADRE Study. Circulation. 2016;134:923\u201333.","journal-title":"Circulation"},{"key":"1026_CR45","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ajpath.2018.12.012","volume":"189","author":"J Ansari","year":"2019","unstructured":"Ansari J, Gavins FNE. Ischemia-reperfusion injury in sickle cell disease: from basics to therapeutics. Am J Pathol. 2019;189:706\u201318.","journal-title":"Am J Pathol"},{"key":"1026_CR46","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1161\/ATVBAHA.110.211615","volume":"30","author":"R Polanowska-Grabowska","year":"2010","unstructured":"Polanowska-Grabowska R, Wallace K, Field JJ, Chen L, Marshall MA, Figler R, et al. P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arterioscler Thromb Vasc Biol. 2010;30:2392\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1026_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/14656566.2018.1548610","volume":"20","author":"L Torres","year":"2019","unstructured":"Torres L, Conran N. Emerging pharmacotherapeutic approaches for the management of sickle cell disease. Expert Opin Pharmacother. 2019;20:173\u201386.","journal-title":"Expert Opin Pharmacother"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01026-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01026-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01026-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:04:38Z","timestamp":1783501478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01026-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1038\/s41443-025-01026-5","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}